Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Vulcan Value Partners - Large Cap. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+7%
YTD+47%
Annualized+0.097%
Positioning StanceCONSTRUCTIVE
Market CapLarge Cap
Digest Analysis
Quick Take
"Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict value discipline through strategic capital reallocation."
Executive Summary
In Q2 2025, Vulcan Value Partners navigated tariff-driven market volatility, leveraging sudden price drops to purchase high-conviction companies at steep discounts. Across composites, they purchased or added to positions in UnitedHealth Group (following a >50% decline driven by guidance withdrawal and CEO transition), IQVIA Holdings, and Forterra plc. These moves were funded by trimmings/exits of companies like Carlyle Group, Heineken, Rentokil, Dun & Bradstreet, and Partners Group. Key contributors to performance during the quarter included Microsoft, Ares Management, ISS A/S, and Littelfuse.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
85%
CautiousHigh
High Conviction (85%)
High-conviction positioning: Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict va...
Growth Outlook
60%
BearishBullish
Neutral (60%)
Market outlook remains above average conviction: Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict va...
Risk Appetite
75%
DefensiveAggressive
Aggressive (75%)
Risk appetite posture is above average conviction: Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict va...
Capital Deployment
90%
De-riskingDeploying
Deploying (90%)
Manager actively deployed capital into high-conviction opportunities. Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict va...
Forward Guidance
50%
CautiousExpansionary
Neutral (50%)
Forward guidance signal: Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict va...
Language Signal
70%
BearishBullish
Bullish (70%)
Tone analysis indicates above average conviction language: Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict va...
Perceived Risk
50%
Low RiskElevated
Moderate Risk (50%)
Perceived risk level is evaluated as moderate conviction. Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict va...
Opportunity Density
80%
ScarceAbundant
Abundant (80%)
Opportunity density index indicates high conviction actionable entry points. Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict va...
Time Horizon
90%
Short-TermLong-Term
Decade+ (90%)
Investment time horizon reflects a high conviction orientation. Vulcan Value Partners capitalized on Q2 2025 tariff concerns and stock-specific sell-offs to opportunistically buy premier assets like UnitedHealth and IQVIA, maintaining strict va...